Adorbs Inc financial data

Location
36 Fourth Ave. N, Saskatchewan, Saskatchewan, Canada
State of incorporation
NV
Fiscal year end
December 31
Former names
Soul Biotechnology Corp (to 10/27/2023)
Latest financial report
10-Q - Q3 2023 - Nov 20, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 9.86 % -8.53%
Quick Ratio 5.79 % +31%
Debt-to-equity 205 %
Return On Equity -539 % -523%
Return On Assets -176 % -227%
Operating Margin -572 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 599M shares
Common Stock, Shares, Outstanding 599M shares +698%
Entity Public Float 0 USD
Common Stock, Value, Issued 599K USD +698%
Weighted Average Number of Shares Outstanding, Basic 599M shares +698%
Weighted Average Number of Shares Outstanding, Diluted 599M shares +698%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 270K USD -61.4%
Cost of Revenue 66.3K USD +12.8%
General and Administrative Expense 276K USD +370%
Operating Income (Loss) -1.54M USD -425%
Nonoperating Income (Expense) -7.07K USD -1474%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.55M USD -425%
Net Income (Loss) Attributable to Parent -1.55M USD -404%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 36.3K USD +183%
Accounts Receivable, after Allowance for Credit Loss, Current 3.1K USD -13.9%
Inventory, Net 38.5K USD -21.6%
Assets, Current 53.4K USD -53.6%
Goodwill 512K USD -7.75%
Assets 884K USD +22.8%
Liabilities, Current 298K USD -73.2%
Liabilities 328K USD -71.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -87.1K USD -135%
Retained Earnings (Accumulated Deficit) -2.04M USD -320%
Stockholders' Equity Attributable to Parent 556K USD
Liabilities and Equity 884K USD +22.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32K USD +11.7%
Net Cash Provided by (Used in) Financing Activities 249 USD -99.4%
Net Cash Provided by (Used in) Investing Activities 20K USD
Common Stock, Shares Authorized 700M shares 0%
Common Stock, Shares, Issued 599M shares +698%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -31.6K USD -218%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.6K USD -82.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.6M USD -258%
Additional Paid in Capital 2.08M USD +7981%
Amortization of Intangible Assets 856K USD +3663%